Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-16

Clinical Trial Update: Ischemic And Bleeding Risk Assessment After TAVR

View source ↗

Summary

This clinical trial update reports a study assessing ischemic and bleeding risk after transcatheter aortic valve replacement (TAVR) in patients with aortic valv…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Niguarda Hospital | Conditions: Aortic Valve Stenosis, Transcatheter Aortic Valve Replacement | Status: RECRUITING